As of 2025-11-11, the Relative Valuation of Halozyme Therapeutics Inc (HALO) is 108.04 USD. This relative valuation is based on P/E multiples. With the latest stock price at 68.01 USD, the upside of Halozyme Therapeutics Inc based on Relative Valuation is 58.9%.
The range of the Relative Valuation is 81.66 - 149.11 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.1x - 23.0x | 20.0x |
| Forward P/E multiples | 19.4x - 31.5x | 25.4x |
| Fair Price | 81.66 - 149.11 | 108.04 |
| Upside | 20.1% - 119.2% | 58.9% |
| Date | P/E |
| 2025-11-07 | 14.32 |
| 2025-11-06 | 14.35 |
| 2025-11-05 | 14.34 |
| 2025-11-04 | 14.28 |
| 2025-11-03 | 13.90 |
| 2025-10-31 | 13.68 |
| 2025-10-30 | 13.57 |
| 2025-10-29 | 13.70 |
| 2025-10-28 | 13.73 |
| 2025-10-27 | 13.82 |
| 2025-10-24 | 13.88 |
| 2025-10-23 | 14.04 |
| 2025-10-22 | 13.80 |
| 2025-10-21 | 14.04 |
| 2025-10-20 | 13.95 |
| 2025-10-17 | 14.07 |
| 2025-10-16 | 14.04 |
| 2025-10-15 | 13.93 |
| 2025-10-14 | 13.99 |
| 2025-10-13 | 13.71 |
| 2025-10-10 | 13.45 |
| 2025-10-09 | 13.67 |
| 2025-10-08 | 13.69 |
| 2025-10-07 | 13.86 |
| 2025-10-06 | 14.06 |
| 2025-10-03 | 14.48 |
| 2025-10-02 | 15.05 |
| 2025-10-01 | 15.73 |
| 2025-09-30 | 15.39 |
| 2025-09-29 | 15.38 |
| 2025-09-26 | 15.48 |
| 2025-09-25 | 15.53 |
| 2025-09-24 | 15.88 |
| 2025-09-23 | 16.28 |
| 2025-09-22 | 16.43 |
| 2025-09-19 | 16.33 |
| 2025-09-18 | 16.09 |
| 2025-09-17 | 15.91 |
| 2025-09-16 | 15.92 |
| 2025-09-15 | 16.02 |
| 2025-09-12 | 16.14 |
| 2025-09-11 | 16.27 |
| 2025-09-10 | 15.91 |
| 2025-09-09 | 15.97 |
| 2025-09-08 | 15.92 |
| 2025-09-05 | 15.73 |
| 2025-09-04 | 15.41 |
| 2025-09-03 | 15.70 |
| 2025-09-02 | 15.39 |
| 2025-08-29 | 15.35 |